Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 16 results.
User Information
Export Records
  1. 1.   Role of IKK alpha in skin squamous cell carcinomas
  2. Park, E. M.; Liu, B. G.; Xia, X. J.; Zhu, F.; Jami, W. B.; Hu, Y. L.
  3. Future Oncology. 2011, Jan; 7(1): 123-134.
  1. 2.   Epimorphic regeneration in mice is p53-independent
  2. Arthur, L. M.; Demarest, R. M.; Clark, L.; Gourevitch, D.; Bedelbaeva, K.; Anderson, R.; Snyder, A.; Capobianco, A. J.; Lieberman, P.; Feigenbaum, L.; Heber-Katz, E.
  3. Cell Cycle. 2010, Sep; 9(18): 3667-3673.
  1. 3.   Generation of Mice with Conditionally Activated Transforming Growth Factor Beta Signaling Through the T beta RI/ALK5 Receptor
  2. Bartholin, L.; Cyprian, F. S.; Vincent, D.; Garcia, C. N.; Martel, S.; Horvat, B.; Berthet, C.; Goddard-Leon, S.; Treilleux, I.; Rimokh, R.; Marie, J. C.
  3. Genesis. 2008 46(12): 724-731.
  1. 4.   The nuclear envelope protein MAN1 regulates TGF beta signaling and vasculogenesis in the embryonic yolk sac
  2. Cohen, T. V.; Kosti, O.; Stewart, C. L.
  3. Development. 2007, Apr; 134(7): 1385-1395.
  1. 5.   Unraveling the pros and cons of interferon-gamma gene regulation
  2. Young, H. A.
  3. Immunity. 2006, MAY; 24(5): 506-507.
  1. 6.   The immunopharmacological properties of transforming growth factor beta
  2. Le, Y. Y.; Yu, X. J.; Ruan, L. F.; Wang, O. M.; Qi, D. F.; Zhu, J. J.; Lu, X. F.; Kong, Y.; Cai, K.; Pang, S. S.; Shi, X. L.; Wang, J. M.
  3. International Immunopharmacology. 2005, DEC; 5(13-14): 1771-1782.
  1. 7.   Transforming growth factor beta 1 (TGF beta 1) polymorphisms and advanced colorectal adenoma
  2. Berndt, S. I.; Huang, W. Y.; Welch, R.; Chanock, S. J.; Pinsky, P.; Weissfeld, J. L.; Hayes, R. B.
  3. Cancer Epidemiology Biomarkers & Prevention. 2005, NOV; 14(11, Part 2 Suppl. S): 2756S-2756S.
  1. 8.   Cited1 is a bifunctional transcriptional cofactor that regulates early nephronic patterning
  2. Plisov, S.; Tsang, M.; Shi, G. B.; Boyle, S.; Yoshino, K.; Dunwoodie, S. L.; Dawid, I. B.; Shioda, T.; Perantoni, A. O.; de Caestecker, M. P.
  3. Journal of the American Society of Nephrology. 2005, JUN; 16(6): 1632-1644.
  1. 9.   Ubiquitin ligase Smurf1 controls osteoblast activity and bone homeostasis by targeting MEKK2 for degradation
  2. Yamashita, M.; Ying, S. X.; Zhang, G. M.; Li, C. L.; Cheng, S. Y.; Deng, C. X.; Zhang, Y. E.
  3. Cell. 2005, APR 8; 121(1): 101-113.
  1. 10.   TGF-beta and vitamin D-3 utilize distinct pathways to suppress IL-12 production and modulate rapid differentiation of human monocytes into CD83(+) dendritic cells
  2. Lyakh, L. A.; Sanford, M.; Chekol, S.; Young, H. A.; Roberts, A. B.
  3. Journal of Immunology. 2005, FEB 15; 174(4): 2061-2070.
  1. 11.   Association, mutual stabilization, and transcriptional activity of the STRA13 and MSP58 proteins
  2. Ivanova, A. V.; Ivanov, S. V.; Lerman, M. L.
  3. Cellular and Molecular Life Sciences. 2005, FEB; 62(4): 471-484.
  1. 12.   Induction of human T cell leukemia virus type I receptors on quiescent naive T lymphocytes by TGF-beta(1,2)
  2. Jones, K. S.; Akel, S.; Petrow-Sadowski, C.; Huang, Y.; Bertolette, D. C.; Ruscetti, F. W.
  3. Journal of Immunology. 2005 174(7): 4262-4270.
  1. 13.   Alterations in mast cell function and survival following in vitro infection with human immunodeficiency viruses-1 through CXCR4
  2. Taub, D. D.; Mikovits, J. A.; Nilsson, G.; Schaffer, E. M.; Key, M. L.; Petrow-Sadowski, C.; Ruscetti, F. W.
  3. Cellular Immunology. 2004, AUG; 230(2): 65-80.
  1. 14.   Tuberous sclerosis complex 2 gene product interacts with human SMAD proteins - A molecular link of two tumor suppressor pathways
  2. Birchenall-Roberts, M. C.; Fu, T.; Bang, O. S.; Dambach, M.; Resau, J. H.; Sadowski, C. L.; Bertolette, D. C.; Lee, H. J.; Kim, S. J.; Ruscetti, F. W.
  3. Journal of Biological Chemistry. 2004 279(24): 25605-25613.
  1. 15.   Cross talk between the smad and the mitogen-activated protein kinase (MAPK) pathways regulates erythroid differentiation of erythroleukemic cells induced by TGF-beta, activin, hydroxyurea and butyrate
  2. Akel, S.; Bertolette, D.; Roberts, A.; Letterio, J.; Ruscetti, F. W.
  3. Blood. 2003 102(11, Part 1): 834A, Abstract 3093-834A, Abstract 3093.
  1. 16.   TGF beta 2, LIF and FGF2 cooperate to induce nephrogenesis
  2. Plisov, S. Y.; Yoshino, K.; Dove, L. F.; Higinbotham, K. G.; Rubin, J. S.; Perantoni, A. O.
  3. Development. 2001 128(7): 1045-1057.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel